NDAQ
69
2
PNC
75
3
TRIP
60
3
CB
65
4
SLG
42
4
EW
51
-2
FFIV
50
6
ACN
54
2
AVY
44
-3
BRK.B
36
-4
AAP
18
-15
WYNN
34
-3
BEN
48
2
ROST
68
-4
WMB
48
-3
ORLY
41
-7
MU
68
2
DIS
62
-2
EXPE
81
-2
EQR
39
-3
NDAQ
69
2
PNC
75
3
TRIP
60
3
CB
65
4
SLG
42
4
EW
51
-2
FFIV
50
6
ACN
54
2
AVY
44
-3
BRK.B
36
-4
AAP
18
-15
WYNN
34
-3
BEN
48
2
ROST
68
-4
WMB
48
-3
ORLY
41
-7
MU
68
2
DIS
62
-2
EXPE
81
-2
EQR
39
-3
Financhill
Back

UiPath, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
53

PATH
UiPath, Inc.

Last Price:
$18.67
Seasonality Move:
-14.79%
Buy
67

GPCR
Structure Therapeutics, Inc.

Last Price:
$68.85
Seasonality Move:
-31.39%
Buy
53
UiPath, Inc. (PATH) is a Buy

Is UiPath, Inc. a Buy, Sell or Hold?

  • The current UiPath, Inc. [PATH] share price is $18.98. The Score for PATH is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • PATH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $66.74. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PATH Stock Price Chart

What is UiPath, Inc.'s stock price today?

  • The UiPath, Inc. share price today is $18.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PATH is experiencing selling pressure, which indicates risk of future bearish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $66.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.

PATH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.97 Buy
Relative Strength Index (14 RSI): 75.14 Buy
Chaikin Money Flow: -10812586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.84 - 16.58) Buy
Bollinger Bands (100): (11.13 - 15.59) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.4 Buy
Relative Strength Index (14 RSI): 80.52 Buy
Chaikin Money Flow: -2951117 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.79 - 46.45) Buy
Bollinger Bands (100): (17.61 - 35.19) Buy

PATH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.57 Buy
20-day SMA: 14.81 Buy
50-day SMA: 15.17 Buy
200-day SMA: 12.66 Buy
8-day EMA: 17.14 Buy
20-day EMA: 15.69 Buy
50-day EMA: 14.79 Buy
200-day EMA: 13.5 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.28 Buy
20-day SMA: 38.08 Buy
50-day SMA: 32.93 Buy
200-day SMA: 23.94 Buy
8-day EMA: 47.33 Buy
20-day EMA: 39.93 Buy
50-day EMA: 33.93 Buy
200-day EMA: 27.69 Buy

UiPath, Inc. Earnings Growth & PATH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.01 per share, and an increase next year of $0.20 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.14 per share.

UiPath, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):